LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,182,130 | -31.6% | 320,129 | -17.7% | 0.05% | -24.6% |
| Q2 2023 | $28,032,480 | +35.3% | 388,800 | +38.0% | 0.06% | +25.0% |
| Q1 2023 | $20,722,367 | +0.4% | 281,707 | -8.8% | 0.05% | -7.1% |
| Q4 2022 | $20,639,797 | -45.8% | 308,979 | -30.2% | 0.06% | -50.4% |
| Q3 2022 | $38,092,000 | -0.4% | 442,359 | +3.2% | 0.11% | -5.8% |
| Q2 2022 | $38,239,000 | +1.5% | 428,585 | +27.9% | 0.12% | +25.0% |
| Q1 2022 | $37,684,000 | -32.7% | 335,003 | -7.6% | 0.10% | -22.0% |
| Q4 2021 | $55,987,000 | +12.2% | 362,469 | +1.2% | 0.12% | +9.8% |
| Q3 2021 | $49,900,000 | -6.3% | 358,162 | -11.7% | 0.11% | -4.3% |
| Q2 2021 | $53,233,000 | +100.1% | 405,776 | +132.6% | 0.12% | +95.0% |
| Q1 2021 | $26,600,000 | -27.6% | 174,482 | -52.7% | 0.06% | -33.3% |
| Q4 2020 | $36,731,000 | +95.6% | 369,081 | +87.4% | 0.09% | +80.0% |
| Q3 2020 | $18,777,000 | – | 196,992 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |